The EU Court of First Instance annuls the Commission’s decision against a pharmaceutical company as it failed to prove the existence of an agreement (Bayer)

Case T-41/96 R Bayer AG v Commission of the European Communities* Where the Commission prohibits a manufacturer of pharmaceutical products from refusing to supply a medicinal product in order to prevent an increase in parallel exports from Member States where the product is marketed

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.